Powder: -20°C for 3 years | In solvent: -80°C for 1 year
RTC-5 (TRC-382) is a phenothiazine compound that has been specifically enhanced for its potent anti-cancer properties. It exhibits considerable effectiveness against an EGFR-driven cancer xenograft model. The mechanism behind its efficacy can be attributed to the simultaneous inhibition of PI3K-AKT and RAS-ERK signaling pathways.
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 298 | 现货 | ||
2 mg | ¥ 428 | 现货 | ||
5 mg | ¥ 689 | 现货 | ||
10 mg | ¥ 1,160 | 现货 | ||
25 mg | ¥ 2,480 | 现货 | ||
50 mg | ¥ 3,980 | 现货 | ||
100 mg | ¥ 6,170 | 现货 | ||
500 mg | ¥ 12,300 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 789 | 现货 |
产品描述 | RTC-5 (TRC-382) is a phenothiazine compound that has been specifically enhanced for its potent anti-cancer properties. It exhibits considerable effectiveness against an EGFR-driven cancer xenograft model. The mechanism behind its efficacy can be attributed to the simultaneous inhibition of PI3K-AKT and RAS-ERK signaling pathways. |
靶点活性 | EGFR: |
体外活性 | H1650肺腺癌细胞增殖在RTC-5 (0-40 μM; 48小时)作用下受到抑制(GI50为12.6μM)。RTC-5 (20-40 μM; 24小时)通过降低磷酸化AKT和磷酸化ERK的表达,负向调节PI3K-AKT和RAS-ERK信号通路[1]。 |
别名 | TRC-382 |
分子量 | 510.96 |
分子式 | C24H22ClF3N2O3S |
CAS No. | 1423077-49-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 13.5 mg/mL (26.4 mM), Sonication is recommended.
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 1.9571 mL | 9.7855 mL | 19.571 mL | 48.9275 mL |
5 mM | 0.3914 mL | 1.9571 mL | 3.9142 mL | 9.7855 mL | |
10 mM | 0.1957 mL | 0.9786 mL | 1.9571 mL | 4.8928 mL | |
20 mM | 0.0979 mL | 0.4893 mL | 0.9786 mL | 2.4464 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
RTC-5 1423077-49-9 Angiogenesis JAK/STAT signaling Tyrosine Kinase/Adaptors EGFR RTC 5 TRC-382 TRC 382 TRC382 RTC5 Inhibitor inhibitor inhibit